+ Budgeting

Draft IPRs from Publicly Financed Research Bill, 2007

In our submission to the Department of Science and Technology (DST) on the draft Intellectual Property Rights from Publicly Financed Research Framework, we noted that “[w]hile we continue to advocate for the development of an intellectual property framework in South Africa that generally facilitates access to essential products, our primary concern is that the legislation and regulations . . . that will result from this process make particular provision for ensuring access to the products of research that were developed using public resources.”

IP rights from publicly financed research framework, 2006

The AIDS Law Project (“the ALP”) takes this opportunity to thank you and the Innovation Fund’s Intellectual Property Management Office for facilitating and hosting the provincial consultation workshop held in Cape Town on 30 March 2006. My colleague Fatima Hassan and I found the event to be extremely useful in understanding the context within which the Intellectual Property Rights (IPR) from Publicly Financed Research Framework (“the policy framework”) is situated. In addition, it provided us with an opportunity to float, consider and refine our formal submissions on the policy framework.

Methodology for conforming with international benchmarks, 2006

Government Notice 2007 of 2005 (Government Gazette No. 28214 of 11 November 2005) calls for submissions – amongst other things – on a methodology for conforming with international benchmarks of the prices of medicines. According to the notice, the methodology will be determined and published by the Minister of Health (“the Minister”) in terms of regulation 5(2)(e) of the Regulations Relating to a Transparent Pricing System for Medicines and Scheduled Substances (“the pricing regulations”).

Appropriate dispensing fee, 2005

In an advertisement placed in the Sunday Times (dated 23 October 2005 and entitled “Call for Submissions”), the Pricing Committee invited “interested parties to provide input on an appropriate dispensing fee as envisaged in terms of section 22G of the Medicines and Related Substances Act, Act No. 101 of 1965” (the Medicines Act). In particular, the advertisement called for interested parties to “provide input on all issues that are relevant to the determination of an appropriate dispensing fee.”